The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024
Typestatutory instrumentDate22 Feb 2024Articles44Cited by15 documents
- 8Amendment to the Medical Devices Regulations 2002
- 9Amendment to regulation 2 (interpretation) in relation to Great Britain
- 10Amendment to regulation 2 (interpretation) in relation to Northern Ireland
- 11Amendment to regulation 2A (medical devices which are qualifying Northern Ireland goods)
- 12Amendment to regulation 3ZA (revocation, transitional and saving provisions in respect of Regulation (EU) 2
- 13Amendment to regulation 4T (references in other legislation to Directives 90/385, 93/42 and 98/79)
- 14Revocation of regulation 19B (requirement to appoint a UK responsible person for general medical devices)
- 15Revocation of regulation 21C (requirement to appoint a UK responsible person for active implantable medical
- 16Amendment to regulation 34A (approval requirement for coronavirus test devices)
- 17New regulation 34D (exemption for coronavirus test devices in conformity with Regulation (EU) 2017/746 and
- 18Amendment to regulation 44 (registration of persons placing in vitro diagnostic medical devices on the mark
- 19Revocation of regulation 44ZA (requirement to appoint a UK responsible person for placing in vitro diagnost
- 20Amendment to the Blood Safety and Quality Regulations 2005
- 21Amendment to the Human Tissue (Quality and Safety for Human Application) Regulations 2007
- 22Amendment to the Legislative and Regulatory Reform (Regulatory Functions) Order 2007
- 23Amendment to the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipm
- 24Amendment to the Waste Electrical and Electronic Equipment Regulations 2013
- 25Amendment to the Economic Growth (Regulatory Functions) Order 2017
- 26Amendment to the Market Surveillance (Northern Ireland) Regulations 2021
- 27Amendment to the Medical Devices (Northern Ireland Protocol) Regulations 2021
- 28Amendment to regulation 2 (extent and application)
- 29Amendment to regulation 3 (interpretation)
- 30Amendment to regulation 4 (scope)
- 31Amendment to regulation 8 (certificates of free sale – fee)
- 32Amendment to regulation 10 (UK(NI) indication)
- 33New Part 2A (Making available on the market and putting into service under Regulation (EU) 2017/746)
- 34New regulation A11 (legal representatives and contact persons for clinical investigations)
- 35Amendment to regulation 13 (arbitration following the refusal of a clinical investigation application)
- 36New Part 3A (Performance studies under Regulation (EU) 2017/746)
- 37Amendment to Part 4
- 38Amendment to regulation 18 (notified bodies)
- 39Amendment to regulation 19 (fees payable in connection with the designation of notified bodies)
- 40Amendment to regulation 20 (language requirements)
- 41Amendment to regulation 23 (offence of breaching certain provisions)
- 42Amendment to regulation 26 (enforcement)
- 43Amendment to Schedule 2 (fees in connection with the designation of notified bodies)
- 44Amendment to Schedule 3 (provisions breach of which is an offence under regulation 23)
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.